×
The Investor Relations website contains information about Cartesian Therapeutics, Inc's business for stockholders, potential investors, and financial ...
People also ask
Annual Reports · Corporate Governance · Overview ... Investor FAQs. Investor Resources ... Prior to the merger, the company traded under the ticker symbol SELB.
(NASDAQ: SELB) (the Company) today announced that it has merged with ... The merger was structured as a stock-for-stock ... Investor Relations: Melissa Forst Argot ...
Selecta Biosciences Inc (US:SELB) has 2 institutional owners and shareholders ... Investor, Type, Avg Price (Est) ... relation to any financial matter you should ...
Investor Resources · Home · Science Menu Toggle. cGMP Facility ... Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update.
Selecta Biosciences, Inc. 617-231-8081 jleaman@selectabio.com. Sarah McCabe. Stern Investor Relations, Inc. +1-212-362-1200 sarah@sternir.com · Selecta ...
This graph assumes the investment of $100 at the market close on June 21, 2016 in our common stock, the Nasdaq Composite Index and the Nasdaq Biotechnology ...
Rating (2,975)
Selecta Biosciences (SELB) will release its next earnings report on Mar 13, 2024 ... investors and does not represent returns that any investor actually attained.
Missing: relations | Show results with:relations
Mar 6, 2023 · ... financial results for the fourth quarter and full year. Blaine brings more than 25 years of experience in Investor Relations, Business ...